“…Early ultrastructural evidence confirmed glutamate immunopositive synaptic vesicles at asymmetric synapses within the PVH (Bartanusz et al, 2004; Decavel and Van den Pol, 1992; Van den Pol, 1990, 1991), suggesting that glutamate may account for as much as 50% of all synapses within the nucleus (Van den Pol, 1991). This report was followed by studies showing glutamate receptor binding and mRNA and protein expression for glutamate receptor subunits in the PVH (Al-Ghoul et al, 1997; Aubry et al, 1996; Eyigor et al, 2001, 2005; Herman et al, 2000; Khan et al, 2000; Kiss et al, 1996; Mateos et al, 1998; Oliver et al, 1996; Petralia and Wenthold, 1996; Sato et al, 1993; Tasker et al, 1998; Van den Pol et al, 1994; Ziegler et al, 2005). In addition to these anatomical data, electrophysiological data from cultured slices have documented functional excitatory responses of PVH neurons to glutamatergic input (Bartanusz et al, 2004; Boudaba et al, 1997; Daftary et al, 1998, 2000; Van den Pol et al, 1990, 1996; Wuarin and Dudek, 1991) and in vivo studies involving glutamate or glutamate receptor antagonist microinjections in the PVH led to stimulation/inhibition of the HPA axis at the level of corticotropin-releasing hormone (CRH), adrenocorticotropic hormone (ACTH), and corticosterone secretion (Cole and Sawchenko, 2002).…”